# Transient proliferation by reversible YAP and mitogen control of the cyclin D1/p27 ratio

**Authors:** Katherine R. Ferrick, Samsara W. Upadhya, Yilin Fan, Nalin Ratnayeke, Mary N. Teruel, Tobias Meyer

PMC · DOI: 10.1038/s42003-026-09590-2 · Communications Biology · 2026-01-29

## TL;DR

The study explores how YAP signaling controls cell proliferation during tissue repair by regulating the cyclin D1/p27 ratio, balancing growth and cancer prevention.

## Contribution

The paper reveals that YAP integrates mitogen and contact signals to regulate the cyclin D1/p27 ratio, enabling transient proliferation without cancer initiation.

## Key findings

- YAP increases the cyclin D1/p27 ratio by enhancing mitogen signaling through receptor upregulation.
- Contact inhibition reverses YAP activity, suppressing mitogen signaling and the cyclin D1/p27 ratio.
- Quantitative imaging shows how signaling pathways coordinate cell cycle entry and exit in epithelial tissues.

## Abstract

Hippo-YAP signaling orchestrates transient proliferation during tissue repair and is therefore an attractive target in regenerative medicine. However, it is unclear how YAP integrates mitogen and contact signals to start and stop proliferation. Here we show that reduced contact inhibition, increased mitogen signaling, and YAP-TEAD activation converge on increasing the nuclear cyclin D1/p27 protein ratio during early G1 phase, towards a threshold ratio that dictates whether individual cells enter or exit the cell cycle. YAP increases this ratio in concert with inducing mitogen signaling, by increasing EGFR and other receptors that signal primarily through ERK. After a delay, contact inhibition suppresses YAP activity, which gradually downregulates mitogen signaling and the cyclin D1/p27 ratio. Thus, critical for regeneration without cancer initiation, robust proliferation responses result from a YAP-induced and receptor-mediated prolonged increase in the cyclin D1/p27 ratio, which is reversed by delayed suppression of receptor signaling after contact inhibition of YAP.

Quantitative image-based cytometry and spatial analysis of proliferation reveal how multiple signalling pathways integrate over time to coordinate both cell cycle entry and exit in epithelial monolayers.

## Linked entities

- **Genes:** YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413], sd (scalloped) [NCBI Gene 32536], ccnd1.S (cyclin D1 S homeolog) [NCBI Gene 379161], IFI27 (interferon alpha inducible protein 27) [NCBI Gene 3429], EGFR (epidermal growth factor receptor) [NCBI Gene 1956]

## Full-text entities

- **Genes:** MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, DCTN6 (dynactin subunit 6) [NCBI Gene 10671] {aka WS-3, WS3, p27}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}
- **Diseases:** cancer (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12957376/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12957376/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12957376/full.md

---
Source: https://tomesphere.com/paper/PMC12957376